Global Blood Therapeutics Files for Sale of of Securities

Global Blood Therapeutics said Thursday in a Securities and Exchange Commission filing that it may from time to time sell as much as $125 million worth of securities.

The securities may include common stock, preferred stock, debt securities, warrants and/or units, it said. It may offer these securities separately or together in units, it said. The shares were down 1.5% in early trading on Thursday.

Leave a Comment